SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-29
👔
Adaptive Biotechnologies Corp
@ADPT_InsiderForm 4 Filing: BOBULSKY SUSAN Sells $102,500 of $ADPT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Adaptive Biotechnologies Corp
Ticker: $ADPT
Transaction Value
$102,500
Price/Share: $20.50
transaction date
2026-06-25
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, BOBULSKY SUSAN, holds the title of Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp.
On 2026-06-25, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $20.50 per share, resulting in a total market-relevant value of $102,500.
Executive Summary Summary
BOBULSKY SUSAN (Chief Commercial Officer, MRD) sold $103K of $ADPT
Post-Transaction Position: 406,775 shares
SEC Accession No: 0001820885-26-000012 (CIK: 1820885)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.